Thieme E-Books & E-Journals -
Back
Pneumologie 2018; 72(S 01): S46
DOI: 10.1055/s-0037-1619239
Sektion 7 – Klinische Pneumologie
Posterbegehung – Titel: Interstitielle und granulomatöse Lungenerkrankungen II
Georg Thieme Verlag KG Stuttgart · New York

Pharmacokinetics (PK) of nintedanib with add-on pirfenidone in patients with idiopathic pulmonary fibrosis (IPF): results from INJOURNEY

M Kreuter
1   Center for Interstitial and Rare Lung Diseases, Pneumology, Thoraxklinik, University of Heidelberg; Member of the German Center for Lung Research
,
WA Wuyts
2   Department of Respiratory Medicine, University Hospitals Leuven
,
JC Grutters
3   Ild Center of Excellence, Department of Pulmonology, St. Antonius Hospital, and Division of Heart & Lungs, University Medical Center Utrecht
,
L Richeldi
4   Catholic University of the Sacred Heart, Rome
,
CJ Ryerson
5   University of British Columbia, Vancouver
,
D Valeyre
6   Assistance Publique-Hôpitaux de Paris; Avicenne Hospital University, Bobigny
,
S Wiebe
7   Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach
,
W Stansen
8   Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein
,
M Quaresma
9   Center for Interstitial and Rare Lung Diseases, Pneumology, Thoraxklinik, University of Heidelberg; Member of the German Center for Lung Research; Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein
,
S Stowasser
8   Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein
,
C Vancheri
10   Department of Clinical and Experimental Medicine, University of Catania
› Author Affiliations